RxDoctor Payments Data

Edgardo Lorenzo, MD

Psychiatry · Avon, CTNPI 1073555744

Payments from drug & device makers

$832in general payments, 2019–2025

Across 38 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$248
  • AbbVie$205
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$88
  • Alkermes, Inc.$83
  • Johnson & Johnson$62
  • E.r. Squibb & Sons, L.L.C.$40
  • plus $105 from 5 others

What the payments were for

  • Food & beverage$72087%
  • Education$11113%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$832 in reported general payments places this provider in the 75th percentile of 644 psychiatry providers in Connecticut.

See all psychiatry providers in Connecticut

Medicare billing

Part B allowed, 2024
$7,855
Medicare patients
27
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate30$83,917
Abilify MaintenaAripiprazole24$64,491
LatudaLurasidone Hcl19$32,175
LybalviOlanzapine/Samidorphan Malate16$25,551
SuboxoneBuprenorphine Hcl/Naloxone Hcl26$20,893
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$3,515
Aripiprazole88$2,713
Olanzapine93$2,213
Quetiapine Fumarate109$1,933
Lurasidone Hcl15$1,432
Bupropion XlBupropion Hcl72$1,417
Atomoxetine Hcl20$1,359
Paliperidone ErPaliperidone14$1,346
Divalproex Sodium ErDivalproex Sodium39$1,026
Clonazepam68$975

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$62$83,91730 claims
Alkermes, Inc.Lybalvi$83$25,55116 claims
Indivior Inc.Suboxone$21$20,89326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 644 psychiatry providers in Connecticut.

Other psychiatry in Avon

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →